Ophthalmics

Bausch + Lomb has gained FDA 510(k) clearance for use in laser-assisted lens fragmentation during cataract surgery.

French ophthalmic device company Quantel Medical has gained U.S. FDA 510(k) clearance for its Optimis Fusion™ integrated laser platform.

IOL and Ophthalmic device company STAAR Surgical has received CE Mark approval for its new Visian® ICL™ Preloaded System.

Abbott has gained CE mark approval for its TECNIS® Symfony Extended Range of Vision intraocular lens (IOL) for the treatment of cataract patients who may also have a diminished ability to focus on near objects (presbyopia).

Bausch + Lomb has announced it has entered into an exclusive license agreement for a three-dimensional surgical navigation technology, the Cirle Surgical Navigation System, from Cirle, Inc., a medical technology incubator based in Miami, Fla.

Just ahead of next weeks ARVO meeting, LKC Technologies tells us it has completed its 400 patient Diabetic Retinopathy Screening Study using the RETeval system. Sounds like results will be promising when they finally share them with us.

An update on breakthroughs in artificial vision research into the use of subretinal implants in the treatment of Retinitis Pignentosa, was presented at the weekend’s World Ophthalmology Congress in Japan.

MRI technology specialist, ScanMed of Resonance Innovations LLC, will be introducing its new Orbit and Mandible Array and Targeting System at this year’s AAPOS (American Association for Pediatric Ophthalmology and Strabismus) Annual Meeting in Palm Springs from April 2-6, 2014.

Implantable lens manufacturer STAAR Surgical Company tells us that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. FDA’s Ophthalmic Devices Panel of the Medical Devices Advisory Committee.

The U.S. FDA has issued 510(k) Clearance for Nidek’s revolutionary new CEM-530 Specular Microscope that acquires images of the corneal endothelium and provides analysis very quickly and easily.

Ocular Therapeutix’s ReSure Sealant has become the first gel sealant for use in stopping fluid from leaking through the incision in a patient’s cornea after cataract surgery with intraocular lens placement in adults. Prior to this approval, stitches were the only option for closing a leaking corneal incision after cataract surgery in the United States

German ophthalmic device company, Retina Implant AG, has seen results from its clinical trial that led to CE mark of the Alpha IMS subretinal implant, presented at the American Academy of Ophthalmology (AAO) annual meeting.

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, has gained CE Mark clearance for its KXL II System, building on the company’s portfolio of technologies aimed at non-surgical correction of ophthalmic conditions.

Ocular Therapeutix, developer of hydrogel based sealant technology for use in ophthalmic cases, has received a guarded nod from the FDA’s review panel.

Last month we trailed the forthcoming acquisition by Abbott of privately held ophthalmic device company OptiMedica Corporation. And now the ink’s drying on the deal which sees Abbott’s vision care business expand into the femtosecond laser-assisted cataract surgery market.

Abbott’s purse strings are undeniably loose as it announces another acquisition, this time of ophthalmic device company OptiMedica Corporation. The acquisition will enable Abbott to expand its vision care business into the femtosecond laser-assisted cataract surgery market.